NOT KNOWN FACTS ABOUT SEMAGLUTUDE WEEKS 13-16 BUNDLE

Thyroid C-cell Tumors: In rodent experiments, semaglutide continues to be revealed to trigger thyroid C-cell tumors. It is unidentified whether this chance applies to humans, but semaglutide is contraindicated in patients with a personal or spouse and children history of medullary thyroid carcinoma (MTC) or clients with Several Endocrine Neoplasia